Death receptor-mediated apoptotic signaling is activated in the brain following infection with west nile virus in the absence of a peripheral immune response

Journal of Virology

Volumn 88, Issue 2, 2014, Pages 1080-1089

  Clarke, Penny ^a   Leser, J Smith ^a   Quick, Eamon D ^a   Dionne, Kalen R ^a   Beckham, J David ^a   Tyler, Kenneth L ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CASPASE 3; CASPASE 8; CASPASE 9; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; CD5 ANTIGEN; DEATH RECEPTOR; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; LIPOCALIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MICROTUBULE ASSOCIATED PROTEIN 2; PROTEIN BCL 2; PROTEIN BID; SERUM AMYLOID A;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; IMMUNE RESPONSE; INNATE IMMUNITY; MICROARRAY ANALYSIS; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PATTERN RECOGNITION; PERIPHERAL IMMUNE RESPONSE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE INJURY; UPREGULATION; VIRUS ENCEPHALITIS; VIRUS PATHOGENESIS; WEST NILE FEVER; WEST NILE FLAVIVIRUS; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BRAIN; CASPASE 3; CASPASE 8; CASPASE 9; FEMALE; HUMANS; MALE; MICE; PERIPHERAL NERVOUS SYSTEM; RECEPTORS, DEATH DOMAIN; SIGNAL TRANSDUCTION; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84891705650     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02944-13     Document Type: Article

References (50)

1. Clarke P, Tyler KL. 2009. Apoptosis in animal models of virus-induced disease. Nat. Rev. Microbiol. 7:144-155. http://dx.doi.org/10.1038/nrmicro2071.
2. Samuel MA, Morrey JD, Diamond MS. 2007. Caspase 3-dependent cell death of neurons contributes to the pathogenesis of West Nile virus encephalitis. J. Virol. 81:2614-2623. http://dx.doi.org/10.1128/JVI.02311-06.
3. Kleinschmidt MC, Michaelis M, Ogbomo H, Doerr HW, Cinatl J, Jr. 2007. Inhibition of apoptosis prevents West Nile virus induced cell death. BMC Microbiol. 7:49. http://dx.doi.org/10.1186/1471-2180-7-49.
4. Ramanathan MP, Chambers JA, Pankhong P, Chattergoon M, Attatippaholkun W, Dang K, Shah N, Weiner DB. 2006. Host cell killing by the West Nile virus NS2B-NS3 proteolytic complex: NS3 alone is sufficient to recruit caspase-8-based apoptotic pathway. Virology 345:56-72. http://dx.doi.org/10.1016/j.virol.2005.08.043.
5. Parquet MC, Kumatori A, Hasebe F, Morita K, Igarashi A. 2001. West Nile virus-induced bax-dependent apoptosis. FEBS Lett. 500:17-24. http://dx.doi.org/10.1016/S0014-5793(01)02573-X.
6. Diamond MS. 2009. Virus and host determinants of West Nile virus pathogenesis. PLoS Pathog. 5:e1000452. http://dx.doi.org/10.1371/journal.ppat.1000452.
7. Shrestha B, Diamond MS. 2004. Role of CD8+ T cells in control of West Nile virus infection. J. Virol. 78:8312-8321. http://dx.doi.org/10.1128/JVI.78.15.8312-8321.2004.
8. Shrestha B, Samuel MA, Diamond MS. 2006. CD8+ T cells require perforin to clear West Nile virus from infected neurons. J. Virol. 80:119-129. http://dx.doi.org/10.1128/JVI.80.1.119-129.2006.
9. Shrestha B, Wang T, Samuel MA, Whitby K, Craft J, Fikrig E, Diamond MS. 2006. Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. J. Virol. 80:5338-5348. http://dx.doi.org/10.1128/JVI.00274-06.
10. Shrestha B, Diamond MS. 2007. Fas ligand interactions contribute to CD8+ T-cell-mediated control of West Nile virus infection in the central nervous system. J. Virol. 81:11749-11757. http://dx.doi.org/10.1128/JVI.01136-07.
11. Brien JD, Uhrlaub JL, Nikolich-Zugich J. 2007. Protective capacity and epitope specificity of CD8(+) T cells responding to lethal West Nile virus infection. Eur. J. Immunol. 37:1855-1863. http://dx.doi.org/10.1002/eji.200737196.
12. Kleinschmidt-DeMasters BK, Marder BA, Levi ME, Laird SP, McNutt JT, Escott EJ, Everson GT, Tyler KL. 2004. Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features. Arch. Neurol. 61:1210-1220. http://dx.doi.org/10.1001/archneur.61.8.1210.
13. Glass WG, Lim JK, Cholera R, Pletnev AG, Gao JL, Murphy PM. 2005. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J. Exp. Med. 202:1087-1098. http://dx.doi.org/10.1084/jem.20042530.
14. Lanteri MC, Heitman JW, Owen RE, Busch T, Gefter N, Kiely N, Kamel HT, Tobler LH, Busch MP, Norris PJ. 2008. Comprehensive analysis of West Nile virus-specific T cell responses in humans. J. Infect. Dis. 197:1296-1306. http://dx.doi.org/10.1086/586898.
15. Shrestha B, Pinto AK, Green S, Bosch I, Diamond MS. 2012. CD8+ T cells use TRAIL to restrict West Nile virus pathogenesis by controlling infection in neurons. J. Virol. 86:8937-8948. http://dx.doi.org/10.1128/JVI.00673-12.
16. Brault AC, Huang CY, Langevin SA, Kinney RM, Bowen RA, Ramey WN, Panella NA, Holmes EC, Powers AM, Miller BR. 2007. A single positively selected West Nile viral mutation confers increased virogenesis in American crows. Nat. Genet. 39:1162-1166. http://dx.doi.org/10.1038/ng2097.
17. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. 2004. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5:R80. http://dx.doi.org/10.1186/gb-2004-5-10-r80.
18. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264. http://dx.doi.org/10.1093/biostatistics/4.2.249.
19. Bruce AJ, Sakhi S, Schreiber SS, Baudry M. 1995. Development of kainic acid and N-methyl-D-aspartic acid toxicity in organotypic hippocampal cultures. Exp. Neurol. 132:209-219. http://dx.doi.org/10.1016/0014-4886(95)90026-8.
20. Noraberg J, Kristensen BW, Zimmer J. 1999. Markers for neuronal degeneration in organotypic slice cultures. Brain Res. Brain Res. Protoc. 3:278-290. http://dx.doi.org/10.1016/S1385-299X(98)00050-6.
21. Stoppini L, Buchs PA, Muller D. 1991. A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods 37:173-182. http://dx.doi.org/10.1016/0165-0270(91)90128-M.
22. Dionne KR, Leser JS, Lorenzen KA, Beckham JD, Tyler KL. 2011. A brain slice culture model of viral encephalitis reveals an innate CNS cytokine response profile and the therapeutic potential of caspase inhibition. Exp. Neurol. 228:222-231. http://dx.doi.org/10.1016/j.expneurol.2011.01.006.
23. Venter M, Myers TG, Wilson MA, Kindt TJ, Paweska JT, Burt FJ, Leman PA, Swanepoel R. 2005. Gene expression in mice infected with West Nile virus strains of different neurovirulence. Virology 342:119-140. http://dx.doi.org/10.1016/j.virol.2005.07.013.
24. Munoz-Erazo L, Natoli R, Provis JM, Madigan MC, King NJ. 2012. Microarray analysis of gene expression in West Nile virus-infected human retinal pigment epithelium. Mol. Vis. 18:730-743.
25. Bourgeois MA, Denslow ND, Seino KS, Barber DS, Long MT. 2011. Gene expression analysis in the thalamus and cerebrum of horses experimentally infected with West Nile virus. PLoS One 6:e24371. http://dx.doi.org/10.1371/journal.pone.0024371.
26. Tyler KL, Leser JS, Phang TL, Clarke P. 2010. Gene expression in the brain during reovirus encephalitis. J. Neurovirol. 16:56-71. http://dx.doi.org/10.3109/13550280903586394.
27. Dionne KR, Zhuang Y, Leser JS, Tyler KL, Clarke P. 9 January 2013. Daxx upregulation within the cytoplasm of reovirus-infected cells is mediated by interferon and contributes to apoptosis. J. Virol. http://dx.doi.org/10.1128/JVI.02324-12.
28. Zhang B, Patel J, Croyle M, Diamond MS, Klein RS. 2010. TNF-alphadependent regulation of CXCR3 expression modulates neuronal survival during West Nile virus encephalitis. J. Neuroimmunol. 224:28-38. http://dx.doi.org/10.1016/j.jneuroim.2010.05.003.
29. Fredericksen BL, Keller BC, Fornek J, Katze MG, Gale M, Jr. 2008. Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1. J. Virol. 82:609-616. http://dx.doi.org/10.1128/JVI.01305-07.
30. Daffis S, Suthar MS, Szretter KJ, Gale M, Jr, Diamond MS. 2009. Induction of IFN-beta and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3 and IRF-7. PLoS Pathog. 5:e1000607. http://dx.doi.org/10.1371/journal.ppat.1000607.
31. Suthar MS, Ma DY, Thomas S, Lund JM, Zhang N, Daffis S, Rudensky AY, Bevan MJ, Clark EA, Kaja MK, Diamond MS, Gale M, Jr. 2010. IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog. 6:e1000757. http://dx.doi.org/10.1371/journal.ppat.1000757.
32. Gilfoy FD, Mason PW. 2007. West Nile virus-induced interferon production is mediated by the double-stranded RNA-dependent protein kinase PKR. J. Virol. 81:11148-11158. http://dx.doi.org/10.1128/JVI.00446-07.
33. Daffis S, Samuel MA, Suthar MS, Gale M, Jr, Diamond MS. 2008. Toll-like receptor 3 has a protective role against West Nile virus infection. J. Virol. 82:10349-10358. http://dx.doi.org/10.1128/JVI.00935-08.
34. Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, Flavell RA. 2004. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 10:1366-1373. http://dx.doi.org/10.1038/nm1140.
35. Town T, Bai F, Wang T, Kaplan AT, Qian F, Montgomery RR, Anderson JF, Flavell RA, Fikrig E. 2009. Toll-like receptor 7 mitigates lethal West Nile encephalitis via interleukin 23-dependent immune cell infiltration and homing. Immunity 30:242-253. http://dx.doi.org/10.1016/j.immuni.2008.11.012.
36. Szretter KJ, Daffis S, Patel J, Suthar MS, Klein RS, Gale M, Jr, Diamond MS. 2010. The innate immune adaptor molecule MyD88 restricts West Nile virus replication and spread in neurons of the central nervous system. J. Virol. 84:12125-12138. http://dx.doi.org/10.1128/JVI.01026-10.
37. Daffis S, Suthar MS, Gale M, Jr, Diamond MS. 2009. Measure and countermeasure: type I IFN (IFN-alpha/beta) antiviral response against West Nile virus. J. Innate Immun. 1:435-445. http://dx.doi.org/10.1159/000226248.
38. Liu WJ, Wang XJ, Clark DC, Lobigs M, Hall RA, Khromykh AA. 2006. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice. J. Virol. 80:2396-2404. http://dx.doi.org/10.1128/JVI.80.5.2396-2404.2006.
39. Scholle F, Mason PW. 2005. West Nile virus replication interferes with both poly(I:C)-induced interferon gene transcription and response to interferon treatment. Virology 342:77-87. http://dx.doi.org/10.1016/j.virol.2005.07.021.
40. Wilson JR, de Sessions PF, Leon MA, Scholle F. 2008. West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction. J. Virol. 82:8262-8271. http://dx.doi.org/10.1128/JVI.00226-08.
41. Fredericksen BL, Gale M, Jr. 2006. West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling. J. Virol. 80:2913-2923. http://dx.doi.org/10.1128/JVI.80.6.2913-2923.2006.
42. Guo JT, Hayashi J, Seeger C. 2005. West Nile virus inhibits the signal transduction pathway of alpha interferon. J. Virol. 79:1343-1350. http://dx.doi.org/10.1128/JVI.79.3.1343-1350.2005.
43. Muñoz-Jordán JL, Laurent-Rolle M, Ashour J, Martínez-Sobrido L, Ashok M, Lipkin WI, García-Sastre A. 2005. Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J. Virol. 79:8004-8013. http://dx.doi.org/10.1128/JVI.79.13.8004-8013.2005.
44. Mackenzie JM, Khromykh AA, Parton RG. 2007. Cholesterol manipulation by West Nile virus perturbs the cellular immune response. Cell Host Microbe 2:229-239. http://dx.doi.org/10.1016/j.chom.2007.09.003.
45. Chan-Tack KM, Forrest G. 2005. Failure of interferon alpha-2b in a patient with West Nile virus meningoencephalitis and acute flaccid paralysis. Scand. J. Infect. Dis. 37:944-946. http://dx.doi.org/10.1080/00365540500262690.
46. Cheeran MC, Hu S, Sheng WS, Rashid A, Peterson PK, Lokensgard JR. 2005. Differential responses of human brain cells to West Nile virus infection. J. Neurovirol. 11:512-524. http://dx.doi.org/10.1080/13550280500384982.
47. Szretter KJ, Samuel MA, Gilfillan S, Fuchs A, Colonna M, Diamond MS. 2009. The immune adaptor molecule SARM modulates tumor necrosis factor alpha production and microglia activation in the brainstem and restricts West Nile Virus pathogenesis. J. Virol. 83:9329-9338. http://dx.doi.org/10.1128/JVI.00836-09.
48. Blakely PK, Kleinschmidt-DeMasters BK, Tyler KL, Irani DN. 2009. Disrupted glutamate transporter expression in the spinal cord with acute flaccid paralysis caused by West Nile virus infection. J. Neuropathol. Exp. Neurol. 68:1061-1072. http://dx.doi.org/10.1097/NEN.0b013e3181b8ba14.
49. Hussmann KL, Samuel MA, Kim KS, Diamond MS, Fredericksen BL. 2013. Differential replication of pathogenic and nonpathogenic strains of West Nile virus within astrocytes. J. Virol. 87:2814-2822. http://dx.doi.org/10.1128/JVI.02577-12.
50. Verma S, Kumar M, Gurjav U, Lum S, Nerurkar VR. 2010. Reversal of West Nile virus-induced blood-brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor. Virology 397:130-138. http://dx.doi.org/10.1016/j.virol.2009.10.036.